1. Li, Jianmin, Zhang, Zhao, Guo, Ke, Zhang, Xinfan, Wang, Zi. 2022. Identification of a key glioblastoma candidate gene, FUBP3, based on weighted gene co-expression network analysis. In BMC neurology, 22, 139. doi:10.1186/s12883-022-02661-x. https://pubmed.ncbi.nlm.nih.gov/35413821/
2. Sharma, Mugdha, Anandram, Seetharam, Ross, Cecil, Srivastava, Sweta. 2022. FUBP3 regulates chronic myeloid leukaemia progression through PRC2 complex regulated PAK1-ERK signalling. In Journal of cellular and molecular medicine, 27, 15-29. doi:10.1111/jcmm.17584. https://pubmed.ncbi.nlm.nih.gov/36478132/
3. Wang, Xiaojing, Guo, Yanhua, Chen, Guo, Zheng, Liduan, Tong, Qiangsong. 2023. Therapeutic targeting of FUBP3 phase separation by GATA2-AS1 inhibits malate-aspartate shuttle and neuroblastoma progression via modulating SUZ12 activity. In Oncogene, 42, 2673-2687. doi:10.1038/s41388-023-02798-0. https://pubmed.ncbi.nlm.nih.gov/37537343/
4. Tu, Rongfu, Ma, Junpeng, Chen, Yule, Lu, Xinlan, Zhang, Chengsheng. 2024. USP7 depletion potentiates HIF2α degradation and inhibits clear cell renal cell carcinoma progression. In Cell death & disease, 15, 749. doi:10.1038/s41419-024-07136-0. https://pubmed.ncbi.nlm.nih.gov/39406703/
5. Gao, Qingzu, Zhou, Rui, Meng, Yuan, Lin, Chuang, Zhao, Liang. 2020. Long noncoding RNA CMPK2 promotes colorectal cancer progression by activating the FUBP3-c-Myc axis. In Oncogene, 39, 3926-3938. doi:10.1038/s41388-020-1266-8. https://pubmed.ncbi.nlm.nih.gov/32203166/
6. Gau, Bing-Huang, Chen, Tsung-Ming, Shih, Yu-Heng J, Sun, H Sunny. 2011. FUBP3 interacts with FGF9 3' microsatellite and positively regulates FGF9 translation. In Nucleic acids research, 39, 3582-93. doi:10.1093/nar/gkq1295. https://pubmed.ncbi.nlm.nih.gov/21252297/